Chemed Corp (CHE)
604.42
+4.01
(+0.67%)
USD |
NYSE |
Apr 22, 16:00
604.77
+0.35
(+0.06%)
Pre-Market: 20:00
Chemed Revenue (Quarterly): 585.91M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 585.91M |
| September 30, 2023 | 564.53M |
| June 30, 2023 | 553.82M |
| March 31, 2023 | 560.16M |
| December 31, 2022 | 546.65M |
| September 30, 2022 | 526.47M |
| June 30, 2022 | 531.29M |
| March 31, 2022 | 530.55M |
| December 31, 2021 | 540.98M |
| September 30, 2021 | 538.67M |
| June 30, 2021 | 532.26M |
| March 31, 2021 | 527.36M |
| December 31, 2020 | 533.29M |
| September 30, 2020 | 528.30M |
| June 30, 2020 | 502.20M |
| March 31, 2020 | 515.80M |
| December 31, 2019 | 522.32M |
| September 30, 2019 | 480.61M |
| June 30, 2019 | 473.58M |
| March 31, 2019 | 462.03M |
| December 31, 2018 | 457.51M |
| September 30, 2018 | 444.15M |
| June 30, 2018 | 441.81M |
| March 31, 2018 | 439.18M |
| December 31, 2017 | 428.36M |
| Date | Value |
|---|---|
| September 30, 2017 | 417.44M |
| June 30, 2017 | 415.06M |
| March 31, 2017 | 405.86M |
| December 31, 2016 | 403.48M |
| September 30, 2016 | 392.61M |
| June 30, 2016 | 390.41M |
| March 31, 2016 | 390.39M |
| December 31, 2015 | 398.59M |
| September 30, 2015 | 386.23M |
| June 30, 2015 | 381.92M |
| March 31, 2015 | 376.65M |
| December 31, 2014 | 379.41M |
| September 30, 2014 | 358.39M |
| June 30, 2014 | 360.18M |
| March 31, 2014 | 358.30M |
| December 31, 2013 | 348.60M |
| September 30, 2013 | 340.89M |
| June 30, 2013 | 357.20M |
| March 31, 2013 | 366.64M |
| December 31, 2012 | 368.58M |
| September 30, 2012 | 354.35M |
| June 30, 2012 | 354.17M |
| March 31, 2012 | 352.94M |
| December 31, 2011 | 350.25M |
| September 30, 2011 | 341.44M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
473.58M
Minimum
Jun 2019
585.91M
Maximum
Dec 2023
531.30M
Average
531.29M
Median
Jun 2022
Revenue (Quarterly) Benchmarks
| Amedisys Inc | 570.79M |
| Addus HomeCare Corp | 276.35M |
| Regional Health Properties Inc | 4.522M |
| OptimizeRx Corp | 16.33M |
| Option Care Health Inc | 1.124B |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 90.05M |
| Total Expenses (Quarterly) | 477.70M |
| EPS Diluted (Quarterly) | 5.90 |
| Enterprise Value | 8.889B |
| Gross Profit Margin (Quarterly) | 38.84% |
| Profit Margin (Quarterly) | 15.37% |
| Earnings Yield | 2.96% |
| Operating Earnings Yield | 3.73% |
| Normalized Earnings Yield | 2.965 |